These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3488860)

  • 1. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis.
    Colucci G; Schaffner F; Paronetto F
    Clin Immunol Immunopathol; 1986 Oct; 41(1):35-42. PubMed ID: 3488860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis.
    Shimizu M; Yuh K; Aoyama S; Ichihara I; Watanabe H; Shijo H; Okumura M
    Liver; 1986 Feb; 6(1):1-6. PubMed ID: 3520203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.
    Ballardini G; Mirakian R; Bianchi FB; Pisi E; Doniach D; Bottazzo GF
    Lancet; 1984 Nov; 2(8410):1009-13. PubMed ID: 6208447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis.
    Nishimoto H; Yamada G; Mizuno M; Tsuji T
    Acta Med Okayama; 1994 Dec; 48(6):317-22. PubMed ID: 7709759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.
    Spengler U; Pape GR; Hoffmann RM; Johnson JP; Eisenburg J; Paumgartner G; Riethmüller G
    Hepatology; 1988; 8(3):459-62. PubMed ID: 3371866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.
    Si L; Whiteside TL; Schade RR; Starzl TE; Van Thiel DH
    J Clin Immunol; 1984 Jul; 4(4):262-72. PubMed ID: 6611346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis.
    Spengler U; Leifeld L; Braunschweiger I; Dumoulin FL; Lechmann M; Sauerbruch T
    J Hepatol; 1997 Jan; 26(1):31-6. PubMed ID: 9148019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Hultcrantz R; Scheynius A
    Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers.
    Bishop GA; Hall BM; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
    Kidney Int; 1986 Mar; 29(3):708-17. PubMed ID: 2939279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines.
    Ayres RC; Neuberger JM; Shaw J; Joplin R; Adams DH
    Gut; 1993 Sep; 34(9):1245-9. PubMed ID: 8104850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.
    Chapman RW; Kelly PM; Heryet A; Jewell DP; Fleming KA
    Gut; 1988 Apr; 29(4):422-7. PubMed ID: 3286382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions.
    Scudeletti M; Indiveri F; Pierri I; Picciotto A; Ferrone S
    Cell Immunol; 1986 Oct; 102(1):227-33. PubMed ID: 2948660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic beta 2-microglobulin distribution in primary biliary cirrhosis.
    Nagafuchi Y; Scheuer PJ
    J Hepatol; 1986; 2(1):73-80. PubMed ID: 3512687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules.
    Nakanuma Y; Yasoshima M; Tsuneyama K; Harada K
    Semin Liver Dis; 1997 Feb; 17(1):35-47. PubMed ID: 9089909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular pathology of primary biliary cirrhosis.
    MacSween RN; Burt AD
    Mol Aspects Med; 1985; 8(3):269-91. PubMed ID: 3913833
    [No Abstract]   [Full Text] [Related]  

  • 17. The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275.
    Chedid A; Mendenhall CL; Moritz TE
    Arch Pathol Lab Med; 1999 May; 123(5):411-4. PubMed ID: 10235499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study.
    Nakanuma Y; Kono N
    Hum Pathol; 1991 May; 22(5):431-6. PubMed ID: 2032692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presenting cells in liver biopsies from patients with primary biliary cirrhosis.
    Ballardini G; Fallani M; Bianchi FB; Pisi E
    Autoimmunity; 1989; 3(2):135-44. PubMed ID: 2491625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.